Document:

CONSENT
      AND WAIVER

     

    THIS
      CONSENT AND WAIVER AGREEMENT (this “Agreement”),
      dated
      as
      of August 12, 2008 is entered into by and among Adrenalina, a Nevada corporation
      (the “Company”),
      and
      the persons identified as “Holders” on the signature pages hereto (the
“Holders”).
      Defined terms not otherwise defined herein shall have the meanings set forth
      in
      both of the Purchase Agreements (as defined below).

     

    WHEREAS,
      pursuant
      to Securities Purchase Agreements, dated November 29, 2007 and February 28,
      2008, (each, a “Purchase
      Agreement”,
      and
      collectively, the “Purchase
      Agreements”),
      among
      the Company and the Holders, the Holders purchased from the Company 5% Senior
      Secured Convertible Debentures (the “Debentures”)
      and
      Warrants (the “Warrants”)
      to
      purchase shares of Common Stock.; and

     

    WHEREAS,
      the
      parties desire to waive and amend certain provisions under the Transaction
      Documents (as defined in both of the Purchase Agreements).

     

    NOW
      THEREFORE,
      for
      good and valuable consideration, the receipt and sufficiency of which is hereby
      acknowledged, each Holder hereby agrees as follows:

     

    1. Subject
      to the terms and conditions hereunder, each Holder hereby waives the Event
      of
      Default under the Debentures due to the Company’s failure to have the Initial
      Registration Statement(s) (as defined in the Registration Rights Agreements)
      declared effective within 180 days of the Closing Date and (ii) the Company’s
      failure to timely pay liquidated damages (and late fees thereon) pursuant to
      Section 2(b) of the Registration Rights Agreements.

    

    2. Subject
      to the terms and conditions hereof, in lieu of the cash payment of accrued
      but
      unpaid liquidated damages plus any late fees thereon under Section 2(b) of
      the
      Registration Rights Agreements, in full satisfaction of such liquidated damages
      and late fees, each Holder agrees to accept, and the Company agrees to pay,
      on
      or prior to the date hereof, the consideration set forth on Schedule
      A
      hereto.

    

    3. As
      a
      result of the changes made to Rule 144 promulgated under the Securities Act
      of
      1933, as amended (the “Securities
      Act”)
      which
      are effective February 15, 2008, other than as to a number of shares of Common
      Stock issuable upon conversion of the Debentures, in the aggregate, and pro-rata
      among all of the Holders, equal to one-third of the number of issued and
      outstanding shares of Common Stock that are held by non-affiliates of the
      Company on the day immediately prior to the date the Company files its next
      amendment to the Registration Statement, the Company's obligations, pursuant
      to
      the Registration Rights Agreements (as defined in the Purchase Agreements),
      to
      register the shares of Common Stock issuable upon conversion and/or exercise
      of
      the Debentures and Warrants, including shares of Common Stock issued in lieu
      of
      accrued and unpaid interest thereon (collectively, the “144
      Eligible Securities”),
      are
      hereby suspended, so long as the
      Company is in compliance with the current public information requirement under
      Rule 144 and the
      Holder may sell the 144 Eligible Securities without any restriction or
      limitation under Rule 144 as of any date after October 26, 2008. Notwithstanding
      anything in the Transaction Documents to the contrary, in connection with the
      foregoing, the Company hereby covenants and agrees that at any time during
      the
      period commencing on the date hereof and ending at such time that all of the
      Underlying Shares can be sold without the requirement that adequate public
      information with respect to the Company be available as set forth in Rule
      144(c)(1) and otherwise without restriction or limitation pursuant to Rule
      144,
      if the Company shall fail for any reason to satisfy the current public
      information requirement under Rule 144(c)(1) (any such failure being referred
      to
      as a “Public
      Information Failure”
and
      the
      Business Day immediately following the date the applicable report giving rise
      to
      the Public Information Failure was due to be filed being referred to as the
      “Public
      Information Failure Date”),
      then,
      as partial relief for the damages to the Holder by reason of any such delay
      in
      or reduction of its ability to sell the Underlying Shares (which remedy shall
      not be exclusive of any other remedies available at law or in equity), the
      Company shall pay to each such holder an amount in cash equal to two percent
      (2.0%) of the aggregate purchase price paid by such holder under each of the
      Purchase Agreement for any Securities then held by such holder on the Public
      Information Failure Date and on every thirtieth day (pro rated for periods
      totaling less than thirty days) thereafter until the earlier of (y) the date
      such Public Information Failure is cured and (z) such date that the public
      information requirement set forth in Rule 144(c)(1) is no longer required
      pursuant to Rule 144. The foregoing payments to which a holder shall be entitled
      are referred to herein as “Public
      Information Failure Payments.”
Public
      Information Failure Payments shall be paid on the earlier of (I) the last day
      of
      the calendar month during which such Public Information Failure Payments are
      incurred and (II) the third Business Day after the event or failure giving
      rise
      to the Public Information Failure Payments is cured. In the event the Company
      fails to make Public Information Failure Payments in a timely manner, such
      Public Information Failure Payments shall bear interest at the rate of 1.5%
      per
      month (prorated for partial months) until paid in full.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    4. The
      Company hereby agrees to cause its legal counsel to issue a legal opinion to
      the
      undersigned Holders and the Company’s Transfer Agent (a “144
      Opinion”)
      that
      the 144 Eligible Securities may be sold pursuant to Rule 144 without volume
      restrictions or manner of sale limitations as of October 26, 2008 and that
      certificates representing the 144 Eligible Securities issuable upon conversion
      of the Debentures, in lieu of cash payments of interest under the Debentures
      or
      a “cashless exercise” of the Warrants may be issued without a restrictive legend
      as required pursuant to Section 4.1 of the Purchase Agreement. Further, after
      October 26, 2008, the Company agrees to cause its legal counsel to keep a
      current 144 Opinion on file with the Holders and the Company’s Transfer Agent at
      all times while the Holders own Securities other than during a Public
      Information Failure.

     

    5. Except
      as
      expressly set forth above, all of the terms and conditions of the Transaction
      Documents shall continue in full force and effect after the execution of this
      Consent and Waiver and shall not be in any way changed, modified or superseded
      by the terms set forth herein. Within four Trading Days of the date hereof,
      the
      Company shall issue a Current Report on Form 8-K, attaching this agreement.
      The
      waivers and amendments set forth herein shall not be effective unless and until
      the Company and all Holders shall have agreed to the terms and conditions
      hereunder and executed and delivered their signature page hereto. In addition,
      the respective obligations, amendments, agreements and waivers of the Holders
      hereunder are subject to the following conditions being met: (a) the accuracy
      in
      all material respects of the representations and warranties of the Company
      contained herein and (b) the performance by the Company of all if its
      obligations, covenants and agreements required to be performed
      hereunder.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    6. This
      Agreement may be executed in two or more counterparts and by facsimile signature
      or otherwise, and each of such counterparts shall be deemed an original and
      all
      of such counterparts together shall constitute one and the same
      agreement.

    

    7. The
      Company has elected to provide all Holders with the same terms and form of
      consent and waiver for the convenience of the Company and not because it was
      required or requested to do so by the Holders. The obligations of each Holder
      under this consent and waiver, and any Transaction Document are several and
      not
      joint with the obligations of any other Holder, and no Holder shall be
      responsible in any way for the performance or non-performance of the obligations
      of any other Holder under this consent and waiver or any Transaction Document.
      Nothing contained herein or in any Transaction Document, and no action taken
      by
      any Holder pursuant thereto, shall be deemed to constitute the Holders as a
      partnership, an association, a joint venture or any other kind of entity, or
      create a presumption that the Holders are in any way acting in concert or as
      a
      group with respect to such obligations or the transactions contemplated by
      this
      consent and waiver or the Transaction Documents. Each Holder shall be entitled
      to independently protect and enforce its rights, including without limitation,
      the rights arising out of this consent and waiver or out of the other
      Transaction Documents, and it shall not be necessary for any other Holder to
      be
      joined as an additional party in any proceeding for such purpose. Each Holder
      has been represented by its own separate legal counsel in their review and
      negotiation of this consent and waiver and the Transaction Documents.

    
 

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    IN
      WITNESS WHEREOF, this Consent and Waiver is executed as of the date first set
      forth above.

    
      	 	 	 
	 	ADRENALINA
              
	 
 	 
 	 
 
	
            	By:  	Jeffrey
              Geller 
	 	
              
Title:
              President and COO

    

     

    [signature
      page(s) of Holders to follow]

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    COUNTERPART
      SIGNATURE PAGE

    OF
      HOLDER
      TO AENA CONSENT AND WAIVER

    
      	 	 	 
	 	Name
              of Holder:
              Enable Capital Mangement
	 
 	 
 	 
 
	
            	By:  	/s/ Adam
              Epstein 
	 	
              
Title: Principal

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    SCHEDULE
      A

    PAYMENT
      OF LIQUIDATED DAMAGES

    

    
      	
              Name     

            	 	
              Accrued
                but unpaid liquidated damages

            	 	
              Shares
                to be issued

            	 
	
              Enable
                Growth Partners, LP 

            	 	
              $

            	
              243,000

            	 	 	
              133,429

            	 
	
              Enable
                Opportunity Partners, LP

            	 	
              $

            	
              27,000

            	 	 	
              14,825Unassociated Document

    June
      27,
      2007

    

    LQD
      Adrenalina, LLC.

    20855
      NE
      16TH Ave. Suite

    Suite
      #C-16

    Miami,
      FL
      33179 

    

    Attention:     Jeffrey
      Geller, President 

    

    Gentlemen:

    

    This
      letter agreement confirms the understanding between LQD Adrenalina, LLC. (the
      “Company”) and Gilford Securities Corporation (“the Banking Advisor”) with
      respect to a possible Transaction involving the Company
      its
      subsidiaries, affiliates and successors,
      and a
      merger or acquisition candidate introduced by the Banking Advisor (the
“Candidate”). The Candidate shall be specifically identified as an addendum to
      this agreement. This agreement shall not apply to any other Candidates except
      upon execution of an additional addendum or an additional agreement. For
      purposes hereof, a “Transaction” shall mean a merger with the Candidate, the
      purchase of all, substantially all or controlling interest of the Candidate,
      its
      subsidiaries, affiliates and successors, or the Company, its subsidiaries,
      affiliates and successors, whether by means of a sale or purchase of stock
      or
      assets, merger, consolidation, exchange offer, or other such transaction of
      a
      like nature. The Banking Advisor shall be the exclusive investment banker for
      the proposed Transaction with the Candidate for the period the transaction
      is
      ongoing, and for one year following the cessation, should discussions resume.
      If
      the
      Company enters into an agreement or consummates a Transaction with the Candidate
      during the term hereof (or within a twelve-month period following termination
      hereof), then the Company shall pay a
      fee
to
      the
      Banking Advisor in the form of cash at closing equal to five percent (5%) of
      the
      Legal Consideration (as defined below) received, exchanged or transferred by
      the
      Company, its affiliates or stockholders. 

     

    For
      the
      purposes of this Agreement, "Legal Consideration" shall mean the total market
      value on the day of closing of stock, securities (in the case of stock or
      securities, valued at market on the day of closing, or if there is no public
      market, valued at fair market value as agreed or, if not, by an independent
      appraiser), cash, assets and all other property (real or personal), debt
      assumed, or benefits exchanged or received, by the Candidate or any of its
      Management in connection with any Transaction, including without limitation
      any
      amounts paid or received by the Company or any person or entity to holders
      of
      warrants, stock purchase rights, straight or convertible securities of the
      Candidate and any subsidiaries or affiliates that are included in the
      Transaction. Legal consideration shall not include salary, sales incentives,
      bonus payments, or similar payments that would ordinarily be considered as
      part
      of executive or employee compensation. All debt instruments or evidences thereof
      and all amounts payable pursuant to any employment agreements, royalty,
      consulting agreements, covenants not to compete, earn-out or contingent payment
      rights or other similar agreements, arrangements or understandings shall be
      valued at the aggregate amount payable there-under, whether such payments are
      absolute or contingent, and irrespective of the period or uncertainty of
      payment, the rate of interest, if any, or the contingent nature thereof. All
      amounts payable pursuant to royalty, consulting agreements, covenants not to
      compete, earn-out, or contingent payment rights shall be valued assuming that
      the financial performance of the Company or the Candidate remains unchanged
      from
      its performance during the prior 12 months. 

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    In
      addition to any fees payable hereunder, the Banking Advisor shall be reimbursed
      by the Company for its reasonable out-of-pocket expenses. 

    

    This
      engagement shall continue in effect until the Company ceases consideration
      of
      the Candidate, another party closes a purchase of the Candidate, or until
      cancelled in writing by either party, except that the provisions of the
      paragraphs regarding compensation, expense reimbursement, indemnification and
      contribution shall survive the term of this Agreement.

    

    At
      the
      end of the earlier of six (3) months from the date hereof, or the end of the
      engagement, for any reason, including but not limited to, those reasons
      referenced above, the Banking Advisor shall be free to show the Candidate to
      other potential buyers and any further professional obligation owed by the
      Banking Advisor to the Company regarding a Transaction with the Candidate shall
      cease, unless both the Banking Advisor and the Company mutually agree in writing
      to continue to pursue a Transaction with the Candidate on a nonexclusive basis.
      

    

    The
      Company agrees to provide the Banking Advisor with the financial and other
      information concerning the Company as the Banking Advisor may reasonably request
      from time to time in connection with the services performed or to be performed
      hereunder. Any information provided by the Company shall be treated by the
      Banking Advisor as confidential and may not be released to any other party
      except upon prior written authorization of the Company. 

    

    Any
      financial advice rendered by the Banking Advisor pursuant to this agreement
      is
      intended solely for the benefit and use of the Company in considering the
      matters to which this agreement relates, and may not be disclosed to any third
      party in any manner without the Banking Advisor’s prior written approval and
      will be treated by the Company as confidential. However, the Company may
      disclose pertinent information to its affiliates and financial backers as
      necessary to evaluate and decide whether to consummate a Transaction.

    

    The
      Company agrees to indemnify and hold the Banking Advisor harmless from and
      against any losses, claims, damages or liabilities (or actions, including
      securityholder actions, in respect thereof) related to or arising out of the
      Banking Advisor’s engagement hereunder or its role in connection herewith, and
      will reimburse the Banking Advisor for all reasonable expenses (including
      counsel fees) as they are incurred by the Banking Advisor in connection with
      investigating, preparing for or defending any such action or claim, whether
      or
      not in connection with pending or threatened litigation in which the Banking
      Advisor is a party. The Company will not, however, be responsible for any
      claims, liabilities, losses, damages or expenses which are finally judicially
      determined to have resulted primarily from the bad faith or gross negligence
      of
      the Banking Advisor. The Company also agrees that the Banking Advisor shall
      not
      have any liability (whether direct or indirect, in contract or tort or
      otherwise) to the Company for or in connection with such engagement, except
      for
      any such liability for losses, claims, damages, liabilities or expenses incurred
      by the Company that result primarily from the bad faith or gross negligence
      of
      the Banking Advisor. In the event that the foregoing indemnity is unavailable
      (except by reason of the bad faith or gross negligence of the Banking Advisor),
      then the Company shall contribute to amount paid or payable by the Banking
      Advisor in respect of its losses, claims, damages and liabilities in such
      proportion as appropriately reflects the relative benefits received by, and
      fault of, the Company and the Banking Advisor in connection with the matters
      as
      to which such losses, claims, damages or liabilities relate and other equitable
      considerations; provided, however, that in no event shall the amount to be
      contributed by the Banking Advisor exceed the amount of the fee actually
      received by the Banking Advisor. The foregoing shall be in addition to any
      rights that the Banking Advisor or any other indemnified person may have at
      common law or otherwise and shall extend to and inure to the benefit of any
      director, officer, employee, agent, member, stockholder, or controlling person
      of the Banking Advisor. The Company hereby consents, to personal jurisdiction,
      service and venue in any court in which any claim which is subject to this
      agreement is brought against the Banking Advisor or any other person entitled
      to
      indemnification or contribution hereunder. The Company will not, without the
      prior written consent of the Banking Advisor, settle, compromise or consent
      to
      the entry of any judgment with respect to any pending or threatened claim,
      action, suit or proceeding in respect of which indemnification or contribution
      may be sought hereunder (whether or not the Banking Advisor is an actual or
      potential party to such claim or action), unless such settlement, compromise
      or
      consent (i) includes an unconditional release of the Banking Advisor from all
      liability arising out of such claim, action, suit or proceeding and (ii) does
      not include a statement as to or an admission of fault, culpability or a failure
      to act by or on behalf of the Banking Advisor.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    This
      Agreement may not be amended or modified except in writing and shall be governed
      by and construed in accordance with the laws of the State of New York, without
      giving effect to conflict of laws provisions. The Company irrevocably submits
      to
      the jurisdiction of any courts of the State of New York or the United States
      District Court for the Southern District of the State of New York for the
      purpose of any suit, action, or other proceeding arising out of this Agreement,
      or any of the agreements or transactions contemplated hereby, which is brought
      by or against the Company. 

     

     

    

    Please
      confirm that the foregoing is in accordance with your understandings and
      agreements with the Banking Advisor by signing and returning to us this letter
      enclosed herewith.

     

    
      
        	 	 	 	 	
                Very
                  truly yours,

              	 
	 	 	 	 	 	 	 	 
	 	 	 	 	
                Gilford
                  Securities Incorporated

              	 
	 	 	 	 	 	 	 	 
	 	 	 	 	
                By:

              	
                /s/
                  Robert A. Maley

              	 
	 	 	 	 	
                Name:

              	 	 
	 	 	 	 	
                Title:

              	
                 

              	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 
	
                CONFIRMED
                  AND AGREED:

              	 	 	 	 	 
	 	 	 	 	 	 	 	 
	
                LQD
                  Adrenalina, LLC.

              	 	 	 	 	 
	 	 	 	 	 	 	 	 
	
                By:

              	
                /s/
                  Jeffrey Geller

              	 	 	 	 	 
	
                Name:

              	 	 	
                 

              	 	 	 
	
                Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00146-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00146-of-00352.parquet"}]]